425: Bleichroeder Acquisition Corp. II Amends Merger Agreement, Increases Financing

Bleichroeder Acquisition Corp. II announced amendments to its merger agreement with Pasqal Holding SAS, including a structural change in merger subsidiaries and an increase in the aggregate subscription price for convertible bonds and warrants.

Summary

• Bleichroeder Acquisition Corp. II (Parent) has entered into Amendment No. 1 to its Agreement and Plan of Merger with Pasqal Holding SAS.
• The amendment involves the assignment of rights and obligations from Bleichroeder Acquisition 2 France (Parent Merger Sub) to Bleichroeder Acquisition France Merger Sub 2 (New Merger Sub), effectively substituting New Merger Sub as the merger party.
• The amendment also updates the transaction structure, recitals, definitions, and related financing arrangements.
• Separately, an amendment to a Securities Purchase Agreement (SPA) increased the aggregate subscription price by $50.0 million to $250.0 million for Senior Unsecured Convertible Bonds and related Investment Warrants.
• A new purchaser, advised by Inflection Point Asset Management LLC, has been added to the SPA.
• An Assignment and Assumption Agreement was also executed, where New Merger Sub assumes all rights and obligations under the SPA from Parent Merger Sub.
• An investor presentation and a press release regarding the filing of a registration statement on Form F-4 for the business combination were also furnished.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as the amendments and increased financing demonstrate continued commitment and progress towards the business combination, despite the inherent complexities of such transactions.

Positives

• Increased financing by $50.0 million, bringing the total to $250.0 million for convertible bonds and warrants, strengthening the capital position for the business combination.
• The amendment to the merger agreement clarifies the transaction structure and ensures continued progress towards the business combination.
• Pasqal's investor presentation highlights significant progress, including a large installed base of high-qubit-count quantum computers and a strong technology roadmap.
• Pasqal has demonstrated quantum advantage in materials science and is targeting significant qubit growth and fault-tolerant capabilities by 2029.
• The company has a robust commercial traction with over 25 identified industrial use cases and a growing revenue stream.

Negatives

• The substitution of merger subsidiaries and amendments to the transaction structure could introduce complexities or delays if not managed effectively.
• The filing mentions potential SPAC redemptions which could reduce the capital available to the combined company and concentrate stock ownership.
• The business combination is subject to customary closing conditions, including shareholder approval and regulatory approvals, which may not be met.

Risks

• The inability to consummate the business combination or the occurrence of any event that could give rise to its termination.
• Failure by Bleichroeder or Pasqal to receive respective shareholder or required regulatory approvals.
• The number of redemption requests made by Bleichroeder's shareholders could leave the combined company with insufficient cash.
• Failure to realize the anticipated benefits of the business combination, including as a result of a delay in consummating the transaction.
• The risk that the business combination disrupts Pasqal's current plans and operations.
• Risks related to Pasqal meeting expected business milestones and the effects of competition on Pasqal's business.
• The ability of the combined company to execute its growth strategy, manage growth profitably, and retain key employees.
• The ability of the combined company to obtain or maintain the listing of its securities on a U.S. national securities exchange.
• The risk from Pasqal pursuing an emerging technology, facing significant technical challenges, and the potential that it may not achieve commercialization or market acceptance.
• Pasqal's financial performance and limited operating history.
• Pasqal's potential need for additional future financing prior to or after the business combination.
• Risks associated with privacy, data protection or cybersecurity incidents and related regulations.
• The use, rate of adoption and regulation of artificial intelligence and machine learning.

Future Outlook

Pasqal expects to deliver 10,000+ physical qubits and 200+ logical qubits with 99.9999% fidelity in 2029. The company aims to be a global leader in operational high-complexity quantum computers, focusing on optimization and simulation use cases. The combined company is expected to operate under the name Pasqal Holding SA and be listed on Nasdaq, with proceeds from the transaction supporting commercialization, roadmap acceleration towards fault-tolerant quantum computing, and global expansion.

Management Comments

• "Todays filing marks meaningful progress as Pasqal moves toward becoming a publicly listed quantum computing company," said Wasiq Bokhari, Chief Executive Officer of Pasqal.
• "We believe our neutral-atom quantum computing platform is uniquely positioned to deliver what the market actually needs: practical, useful quantum computing on business-relevant problems today, and a credible, engineered path to industry-leading fault-tolerant quantum computing tomorrow - on the same hardware."
• "This transaction is intended to provide Pasqal with the public market platform and capital to accelerate our roadmap, scale our technology, and deliver real-world quantum value to customers and partners globally."

Industry Context

StockSavvy.ai notes that this filing signifies a critical step in the ongoing consolidation and maturation of the quantum computing sector. The amendments and increased financing indicate a commitment to advancing Pasqal's technology and market position, aligning with the broader industry trend towards practical applications and commercialization of quantum solutions. The focus on neutral-atom technology positions Pasqal against competitors utilizing superconducting or trapped-ion architectures, highlighting the diverse technological approaches in the race for quantum advantage.

Comparison to Industry Standards

• Pasqal's neutral atom technology is presented as a scalable alternative to superconducting (IBM, Google) and trapped ion (IonQ, Quantinuum) qubits, with a target of 10,000-50,000 qubits per QPU compared to ~3,000-6,000 for superconducting and ~100-200 for trapped ions.
• Pasqal has demonstrated 1,024 atoms in a register, surpassing the qubit counts of many competitors in the neutral atom space.
• The company claims to have achieved quantum advantage in materials science (TmMgGaO4 simulation), a benchmark that few quantum computing companies have demonstrably reached.
• Pasqal's valuation of ~$2.0 billion pre-money is presented as being in line with other recent de-SPAC transactions in the technology sector, such as those involving IonQ, Rigetti, and D-Wave.

Corporate Governance

Related Party Transactions

• Michel Combes holds 10 Parent Merger Sub Shares, indicating a related party interest in the pre-merger entity.

Stakeholder Impact

• Shareholders of Bleichroeder: Will vote on the business combination and may face dilution from new share issuances and potential concentration of ownership if redemptions occur.
• Pasqal Shareholders: Will exchange their shares for shares in the combined public company, subject to the terms of the business combination.
• Investors in Convertible Financing: Will hold Senior Unsecured Convertible Bonds and Investment Warrants, with an increased aggregate subscription price.
• Employees of Pasqal: Will become employees of a publicly traded company, potentially benefiting from equity incentives and facing new corporate governance requirements.
• Customers and Partners: Will continue to engage with Pasqal's quantum computing solutions, with potential for expanded offerings and global reach of the combined entity.

Next Steps

• The business combination remains subject to customary closing conditions, including the effectiveness of the Registration Statement, approval by Bleichroeder shareholders, receipt of regulatory approvals, and Nasdaq listing approval.
• Upon closing, the combined company is expected to operate under the name Pasqal Holding SA and be listed on Nasdaq.
• The Registration Statement on Form F-4 will be declared effective by the SEC, after which a definitive proxy statement/prospectus will be mailed to shareholders.

Key Dates

Recommendation

The amendments and increased financing are positive steps in the ongoing business combination process, indicating continued commitment. However, the transaction is still subject to customary closing conditions, including shareholder and regulatory approvals. The forward-looking statements highlight significant technological potential but also substantial risks inherent in the emerging quantum computing industry. Investors should await the effectiveness of the registration statement and further clarity on closing conditions before making a definitive investment decision. A 'hold' recommendation reflects the current stage of progress and the balance of potential upside against inherent risks.

Keywords

quantum computing, Pasqal, Bleichroeder Acquisition Corp. II, business combination, merger agreement, securities purchase agreement, convertible bonds, neutral atom technology, SPAC, Form F-4, registration statement